VECT vs. ALVO, GNCAQ, ATNFW, SXTPW, ACONW, AIMDW, DRTSW, ALVOW, AONCW, and AONC
Should you be buying VectivBio stock or one of its competitors? The main competitors of VectivBio include Alvotech (ALVO), Genocea Biosciences (GNCAQ), 180 Life Sciences (ATNFW), 60 Degrees Pharmaceuticals (SXTPW), Aclarion (ACONW), Ainos (AIMDW), Alpha Tau Medical (DRTSW), Alvotech (ALVOW), American Oncology Network (AONCW), and American Oncology Network (AONC). These companies are all part of the "medical" sector.
Alvotech (NYSE:ALVO) and VectivBio (NASDAQ:VECT) are both medical companies, but which is the superior investment? We will compare the two companies based on the strength of their earnings, analyst recommendations, community ranking, valuation, profitability, dividends, risk, media sentiment and institutional ownership.
VectivBio has lower revenue, but higher earnings than Alvotech.
VectivBio received 6 more outperform votes than Alvotech when rated by MarketBeat users. Likewise, 43.48% of users gave VectivBio an outperform vote while only 36.36% of users gave Alvotech an outperform vote.
Alvotech currently has a consensus price target of $12.67, indicating a potential downside of 6.17%. Given VectivBio's stronger consensus rating and higher possible upside, equities analysts clearly believe Alvotech is more favorable than VectivBio.
VectivBio has a net margin of 0.00% compared to VectivBio's net margin of -967.97%.
In the previous week, Alvotech had 1 more articles in the media than VectivBio. MarketBeat recorded 4 mentions for Alvotech and 3 mentions for VectivBio. Alvotech's average media sentiment score of 0.70 beat VectivBio's score of 0.00 indicating that VectivBio is being referred to more favorably in the news media.
Summary
VectivBio beats Alvotech on 6 of the 11 factors compared between the two stocks.
Get VectivBio News Delivered to You Automatically
Sign up to receive the latest news and ratings for VECT and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding VECT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
VectivBio Competitors List
Related Companies and Tools
